Skip to Content

M L 6 (Levothyroxine Sodium 75 mcg (0.075 mg))

Pill with imprint M L 6 is Purple, Capsule-shape and has been identified as Levothyroxine Sodium 75 mcg (0.075 mg). It is supplied by Mylan Pharmaceuticals Inc..

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 75 mcg (0.075 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L 6

Levothyroxine sodium 75 mcg (0.075 mg) M L 6 Front
Levothyroxine sodium 75 mcg (0.075 mg) M L 6 Back
Levothyroxine sodium 75 mcg (0.075 mg) M L 6
Levothyroxine sodium 75 mcg (0.075 mg) M L 6

Levothyroxine Sodium

M L 6
75 mcg (0.075 mg)
9.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-1805 Mylan Pharmaceuticals Inc.
51079-0441 UDL Laboratories Inc.
54569-5653 A-S Medication Solutions, LLC (repackager)
49999-0793 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.